Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency-Reference-Cited by-同舟云学术

Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency

Published:2022-11 Issue: Volume: Page:
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

KHAN MUHAMMAD SHAHZEB,ANKER STEFAN D.,FRIEDE TIM,JANKOWSKA EWA A.,METRA MARCO,PIÑA ILEANA L,COATS ANDREW JS,ROSANO GIUSEPPE,ROUBERT BERNARD,GOEHRING UDO-MICHAEL,DORIGOTTI FABIO,COMIN-COLET JOSEP,VANVELDHUISEN DIRK J,FILIPPATOS GERASIMOS S.,PONIKOWSKI PIOTR,BUTLER JAVED

Funder

Vifor Pharma

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Improving functional capacity in heart failure: the need for a multifaceted approach;Arena;Curr Opin Cardiol,2014

2. Changing preferences for survival after hospitalization with advanced heart failure;Stevenson;J Am Coll Cardiol,2008

3. Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review;Cordoba;BMJ,2010

4. Prioritizing functional capacity as a principal end point for therapies oriented to older adults with cardiovascular disease: a scientific statement for healthcare professionals from the American Heart Association;Forman;Circulation,2017

5. Triangulating clinically meaningful change in the six-minute walk test in individuals with chronic heart failure: a systematic review;Shoemaker;Cardiopulm Phys Ther J,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous iron therapy in heart failure with preserved ejection fraction: how far have we walked?;European Heart Journal;2024-08-26

2. Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial;European Heart Journal;2024-08-26

3. Changes in 6‐min walk test is an independent predictor of death in chronic heart failure with reduced ejection fraction;European Journal of Heart Failure;2024-07-26

4. Semaglutide, Obesity-Related Heart Failure, and Type 2 Diabetes;New England Journal of Medicine;2024-07-25

5. Association between self-reported and objectively assessed physical functioning in the general population;Scientific Reports;2024-07-14